
|Articles|May 15, 2002
FDA Briefs
FDA approves Refractec's CK nonlaser procedure for farsightedness
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
Inside the clinic: Surgeon shares real-world experience
3
What changed in glaucoma care in 2025: Surgeon perspective
4
PRIMAvera study: Central vision improvement with subretinal implant
5












































